Monitor for additional insider buying or a material catalyst (e.g., pipeline update, partnership) that could validate this conviction buy. The gift of shares preceding the purchase may indicate estate planning rather than a bearish signal, but the net insider activity (gifts + buy) is mixed. Given poor historical follow-through on PRTA insider buys, treat this as a modest positive signal until corroborated by fundamental news.
PRTA drugs
PRTA drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 21 $9.45entry
- T+1 · 3mo ago −0.63%α −0.34% · $9.39
- T+5 · 3mo ago −1.27%α −1.74% · $9.33
- T+20 · 8w ago −9.95%α −9.42% · $8.51
- T+60 · 20h ago −15.66%α −12.30% · $7.97
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
10% owner William Scully made a $439K open-market purchase of PRTA shares at $8.79, adding to his position after gifting over 963K shares earlier in the same week. The buy is modest relative to the $477M market cap (~0.09%), but as a standalone conviction buy by a major insider, it signals confidence at a depressed price.
Key Financial Metrics
Key Facts
- 10% owner William Scully purchased 50,000 shares at $8.79 for $439K on 2026-08-20
- Purchase represents ~0.09% of PRTA's $477M market cap
- Scully also gifted 963,553 shares (non-cash) on 2026-08-17 and 2026-08-18
- PRTA has 67% analyst bullish consensus (2 Strong Buy, 6 Buy)
Financial Impact
$439K open-market purchase by 10% owner
Risk Factors
- Insider gifts of 963K shares before the buy could indicate non-trading motives (e.g., estate planning) rather than pure conviction
- Biotech sector risk: PRTA's stock is volatile and dependent on clinical trial outcomes
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001045463-26-000014 |
Track record
20 reports on PRTA
8 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +14.11% at T+60 after the Jun 12, 2026 report. 9 of 11 went positive at some point.
Filters
- Nov 13, 20263d ago 3 Neutral 1/10 Entry $8.16 to $7.97 Now $7.97 −2.33% ▼ −2.33% −0.42% vs SPY
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $8.16 to $7.97 Now $7.97 −2.33% ▼ −2.33% −0.42% vs SPY
- Nov 10, 20266d ago Insider Buy Bullish 5/10 Entry $8.56 to $8.73 Now $7.97 −6.89% ▲ +1.99% +0.67% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $7.97 to $8.78 Now $7.97 −0.00% ▲ +10.10% +7.73% vs SPY
- Oct 29, 202618d ago 8-K Bearish 6/10 Entry $8.47 to $8.29 Now $7.97 +5.90% ▲ +2.13% +1.65% vs SPY
- Oct 26, 202621d ago Insider Buy Bullish 5/10 Entry $8.81 to $9.10 Now $7.97 −9.53% ▲ +3.29% +2.95% vs SPY
- Oct 15, 20264w ago Insider Buy Bullish 5/10 Entry $8.35 to $8.48 Now $7.97 −4.55% ▲ +1.56% +1.13% vs SPY
- Sep 30, 20266w ago Insider Buy Bullish 5/10 Entry $8.54 to $8.36 Now $7.97 −6.67% ▼ −2.11% −2.85% vs SPY
- Sep 29, 20266w ago Insider Buy Bullish 5/10 Entry $8.38 to $8.54 Now $7.97 −4.89% ▲ +1.91% +1.73% vs SPY
- Sep 21, 20268w ago Insider Buy Bullish 6/10 Entry $8.99 to $8.68 Now $7.97 −11.35% ▼ −3.45% −2.73% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers